Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

7
Number of overlapping holdings
11.7%
% of XLV's 60 holdings also in IHE
19.4%
% of IHE's 37 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus IHE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XLV |
Weight in IHE |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 13.4% | 25.8% | 13.4% | |
JOHNSON & JOHNSON | 7.7% | 24.4% | 7.7% | |
MERCK & CO. INC. | 4.0% | 4.2% | 4.0% | |
PFIZER INC | 2.5% | 4.3% | 2.5% | |
BRISTOL-MYERS SQUIBB CO | 2.0% | 4.1% | 2.0% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to IHE
UNITEDHEALTH GROUP INC | 8.5% | |
ABBVIE INC | 6.2% | |
ABBOTT LABORATORIES | 4.6% | |
INTUITIVE SURGICAL INC | 3.5% | |
THERMO FISHER SCIENTIFIC INC | 3.3% | |
AMGEN INC | 3.0% | |
BOSTON SCIENTIFIC CORP | 2.8% | |
GILEAD SCIENCES INC | 2.6% | |
VERTEX PHARMACEUTICALS INC | 2.5% | |
DANAHER CORP | 2.4% |
XLV Underweight Relative to IHE
JOHNSON & JOHNSON | -16.7% | |
ELI LILLY & CO | -12.4% | |
ROYALTY PHARMA PLC CLASS A | -5.0% | |
VIATRIS, INC. | -3.9% | |
ZOETIS INC | -3.3% | |
JAZZ PHARMACEUTICALS PLC | -2.9% | |
CORCEPT THERAPEUTICS INC | -2.7% | |
BRISTOL-MYERS SQUIBB CO | -2.1% | |
AXSOME THERAPEUTICS, INC. | -2.0% | |
ELANCO ANIMAL HEALTH, INC. | -1.9% |